Nishadil
Signup Signin
Delhi | 25°C (windy)
FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review

FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review
Carvana's Resilience: Why Wall Street Remains Bullish Amidst Subprime Loan Scrutiny

Carvana's Resilience: Why Wall Street Remains Bullish Amidst Subprime Loan Scrutiny
The Unseen Engine: How Unprofitable Small-Caps Are Propelling the Russell 2000's Surprising Ascent

The Unseen Engine: How Unprofitable Small-Caps Are Propelling the Russell 2000's Surprising Ascent
Alibaba Soars: What's Driving the E-commerce Giant Past Its 52-Week High?

Alibaba Soars: What's Driving the E-commerce Giant Past Its 52-Week High?
Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File

Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File
American Express Platinum: Navigating Fatigue for Future Growth

American Express Platinum: Navigating Fatigue for Future Growth
Unlocking Apple's Hidden Potential: Why Analysts Say the Street is Seriously Underestimating AAPL's Next Growth Wave

Unlocking Apple's Hidden Potential: Why Analysts Say the Street is Seriously Underestimating AAPL's Next Growth Wave
Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside

Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside
FuelCell Energy Soars: Hopes Ignited, But Analysts Warn of Sky-High Valuation

FuelCell Energy Soars: Hopes Ignited, But Analysts Warn of Sky-High Valuation
Unlocking Potential: Bright Minds Biosciences Poised for Growth Amidst Vast Patient Needs

Unlocking Potential: Bright Minds Biosciences Poised for Growth Amidst Vast Patient Needs
PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment

PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment
Dianthus Unlocks Promising Future with Breakthrough Trial Results and Analyst Acclaim

Dianthus Unlocks Promising Future with Breakthrough Trial Results and Analyst Acclaim
Phreesia's Epic Alliance Deepens: A Game Changer or Integration Hurdle?

Phreesia's Epic Alliance Deepens: A Game Changer or Integration Hurdle?
Ciena Soars to New Heights with Record Orders: Analyst Raises Forecasts on Unprecedented Visibility

Ciena Soars to New Heights with Record Orders: Analyst Raises Forecasts on Unprecedented Visibility
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Telix Pharmaceuticals Faces Second Major FDA Hurdle for Critical Kidney Cancer Diagnostic

Telix Pharmaceuticals Faces Second Major FDA Hurdle for Critical Kidney Cancer Diagnostic
The Global Skies Await: Are US eVTOL Pioneers Falling Behind in the Race for Future Flight?

The Global Skies Await: Are US eVTOL Pioneers Falling Behind in the Race for Future Flight?
Kyverna Therapeutics: Charting a Course for Revolutionary Autoimmune CAR T Therapy by 2026

Kyverna Therapeutics: Charting a Course for Revolutionary Autoimmune CAR T Therapy by 2026
Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon

Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon
Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval

Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval
Buffett's Bold Bet: Why Berkshire Hathaway Is Doubling Down on UnitedHealth

Buffett's Bold Bet: Why Berkshire Hathaway Is Doubling Down on UnitedHealth
Load more..